𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes

✍ Scribed by M. Lindauer; T. Stanislawski; Annett Häußler; Edith Antunes; Anne Cellary; Christoph Huber; M. Theobald


Publisher
Springer
Year
1997
Tongue
English
Weight
554 KB
Volume
76
Category
Article
ISSN
0946-2716

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Detection of peptide-specific cytotoxic
✍ Nobuaki Suzuki; Yoshiaki Maeda; Shoko Tanaka; Naoya Hida; Takashi Mine; Koutaro 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 143 KB

## Abstract The prognosis of pancreatic cancer is extremely poor with a 5‐year survival of approximately 3%. Thus, the development of new treatment modalities, including a specific immunotherapy, is required. Our study investigated whether cytotoxic T‐lymphocyte (CTL) precursors reacting to peptide

Cytotoxic effects of γδ T cells expanded
✍ Kiyoshi Sato; Shinya Kimura; Hidekazu Segawa; Asumi Yokota; Seiji Matsumoto; Jun 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 331 KB

## Abstract Nitrogen containing‐bisphosphonates (N‐BPs), widely used to treat bone diseases, have direct antitumor effects __via__ the inactivation of Ras proteins. In addition to the direct antitumor activities, N‐BPs expand gdγδT cells, which exhibit major histocompatibility complex‐unrestricted

Identification of HER2/neu-derived pepti
✍ Koji Kono; Yang Rongcun; Jehad Charo; Fumiko Ichihara; Esteban Celis; Alessandro 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB 👁 2 views

We have derived HLA-A2.1-restricted, gastric cancerspecific cytotoxic T lymphocyte (CTL) lines by repetitive in vitro stimulation of tumor-associated lymphocytes (TAL) with autologous tumor cells. The HER2/neu specificity of these gastric cancer-specific CTLs was demonstrated using HER2/neu-transfec

Identification of a glioma antigen, GARC
✍ Yukihiko Iizuka; Hidefumi Kojima; Tetsuji Kobata; Takeshi Kawase; Yutaka Kawakam 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 505 KB

## Abstract Despite several ongoing clinical trials of immunotherapies against glioma, few glioma‐specific antigens recognized by cytotoxic T lymphocytes (CTLs) have been identified. We recently demonstrated that intratumoral inoculation with herpes simplex virus (HSV) as a cancer vaccine activates